Medifast provided earnings guidance for the first quarter of 2024. For the period, the company expects revenue to be in the range of $155 million to $175 million and diluted EPS to be in the range of $0.25 to $0.95.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.83 USD | +0.31% | -8.68% | -66.04% |
Apr. 30 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
Apr. 30 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-66.04% | 244M | |
+13.97% | 8.2B | |
+5.29% | 7.61B | |
+0.60% | 5.95B | |
-6.04% | 3.72B | |
-10.75% | 3.57B | |
-7.53% | 1.27B | |
-29.55% | 1.07B | |
+14.57% | 988M | |
-12.85% | 890M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast Provides Earnings Guidance for the First Quarter of 2024